Guidelines for Genetic Testing and Management of Alport Syndrome
- PMID: 34930753
- PMCID: PMC8763160
- DOI: 10.2215/CJN.04230321
Guidelines for Genetic Testing and Management of Alport Syndrome
Erratum in
-
Correction: Guidelines for Genetic Testing and Management of Alport Syndrome.Clin J Am Soc Nephrol. 2023 Apr 1;18(4):510. doi: 10.2215/CJN.0000000000000095. Clin J Am Soc Nephrol. 2023. PMID: 37026751 Free PMC article. No abstract available.
Abstract
Genetic testing for pathogenic COL4A3-5 variants is usually undertaken to investigate the cause of persistent hematuria, especially with a family history of hematuria or kidney function impairment. Alport syndrome experts now advocate genetic testing for persistent hematuria, even when a heterozygous pathogenic COL4A3 or COL4A4 is suspected, and cascade testing of their first-degree family members because of their risk of impaired kidney function. The experts recommend too that COL4A3 or COL4A4 heterozygotes do not act as kidney donors. Testing for variants in the COL4A3-COL4A5 genes should also be performed for persistent proteinuria and steroid-resistant nephrotic syndrome due to suspected inherited FSGS and for familial IgA glomerulonephritis and kidney failure of unknown cause.
Keywords: Alport syndrome; COL4A3; COL4A4; COL4A5; FSGS; collagen IV; digenic Alport syndrome; genetic testing; kidney cysts; thin basement membrane nephropathy.
Copyright © 2022 by the American Society of Nephrology.
References
-
- Grunfeld JP: Hereditary renal diseases. Saudi J Kidney Dis Transpl 8: 227–234, 1997 - PubMed
-
- Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY: Thin basement membrane nephropathy. Kidney Int 64: 1169–1178, 2003 - PubMed
-
- Gibson J, Fieldhouse R, Chan MM, Sadeghi-Alavijeh O, Burnett L, Izzi V, Persikov AV, Gale DP, Storey H, Savige J: Prevalence estimates of predicted pathogenic COL4A3–COL4A5 variants in a population sequencing database and their implications for alport syndrome. J Am Soc Nephrol 32: 2273–2290, 2021 - PMC - PubMed
-
- Gubler M, Levy M, Broyer M, Naizot C, Gonzales G, Perrin D, Habib R: Alport’s syndrome. A report of 58 cases and a review of the literature. Am J Med 70: 493–505, 1981 - PubMed
-
- Feingold J, Bois E, Chompret A, Broyer M, Gubler MC, Grünfeld JP: Genetic heterogeneity of Alport syndrome. Kidney Int 27: 672–677, 1985 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous